Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Radiomics.bio develops proprietary AI-driven software solutions that extract quantitative features from standard medical images to support precision medicine. Their technology enables improved cancer diagnosis, therapy evaluation, prediction of treatment effects, and patient stratification. The company collaborates with biopharma and device companies to optimize clinical trials by providing advanced analytics on tumor heterogeneity using non-invasive imaging data. They have an international presence with clients across the EU, US, Africa, and Australia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Radiomics.